Stock listing

NASDAQ:HOTH Hoth Therapeutics, Inc. Stock

Home listing (NASDAQ) of Hoth Therapeutics, Inc.

Follow Hoth Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HOTH

$0.28 USD -0.02 (-7.4%)

Close on Nov 19, 2026 · Data provided by Twelve Data

Past year -75.7% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.272 – $0.31 USDNov 19, 2026
Volume
271,337 sharesNov 19, 2026
Market cap
$4.55M USDAt the close on Nov 19, 2026 · price × 16.27M shares outstanding
52-week range
$0.272 – $2.45 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$219,012 USDMedian day 242,281 shares · last 3 months, Aug 19, 2026 – Nov 19, 2026
Hoth Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HOTH · Home$0.28 USD-0.022 (-7.4%)271,337$0.302$0.31$0.272$0.302Close on Nov 19, 2026

Data provided by Twelve Data

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · NASDAQ:HOTH · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.28-0.022-7.4%$0.302$0.31$0.272271,337
$0.302-0.015-4.6%$0.321$0.322$0.30162,638
$0.317-0.004-1.2%$0.324$0.324$0.301258,851
$0.321+0.000.0%$0.33$0.336$0.308162,333
$0.321-0.024-7.0%$0.335$0.345$0.316221,785
$0.345-0.026-7.0%$0.36$0.374$0.345148,885
$0.371-0.009-2.4%$0.37$0.383$0.332620,978
$0.38-0.015-3.9%$0.399$0.399$0.37154,625
$0.395-0.006-1.4%$0.402$0.408$0.391148,899
$0.401-0.001-0.2%$0.402$0.425$0.391123,804
$0.402-0.04-9.1%$0.44$0.44$0.38393,395
$0.442-0.02-4.3%$0.436$0.475$0.434321,430
$0.462+0.013+2.9%$0.47$0.499$0.431,270,852
$0.449-0.037-7.7%$0.487$0.498$0.441248,547
$0.487-0.029-5.6%$0.516$0.525$0.47331,367
$0.516-0.027-5.0%$0.551$0.551$0.51131,506
$0.543+0.005+1.0%$0.537$0.553$0.535117,337
$0.537+0.027+5.4%$0.51$0.55$0.50265,852
$0.51-0.038-6.8%$0.55$0.555$0.507181,144
$0.548+0.015+2.8%$0.533$0.557$0.52898,821
$0.533+0.007+1.4%$0.52$0.548$0.51313,260
$0.525-0.006-1.1%$0.549$0.55$0.522170,718
$0.531+0.034+6.9%$0.538$0.58$0.53942,224
$0.497-0.01-2.0%$0.501$0.539$0.483426,388
$0.507-0.03-5.6%$0.549$0.55$0.503236,014
$0.537+0.005+0.9%$0.536$0.547$0.51200,156
$0.532-0.038-6.7%$0.57$0.57$0.53305,237
$0.571-0.029-4.9%$0.602$0.61$0.563602,603
$0.60-0.049-7.6%$0.65$0.651$0.595309,353
$0.649+0.003+0.5%$0.657$0.678$0.647111,256
$0.646-0.024-3.6%$0.668$0.68$0.633262,321
$0.67-0.031-4.5%$0.695$0.695$0.665198,963
$0.701-0.009-1.2%$0.73$0.765$0.6871,209,980
$0.71+0.012+1.8%$0.69$0.726$0.66287,664
$0.698+0.007+1.0%$0.71$0.724$0.694177,365
$0.691-0.024-3.3%$0.715$0.73$0.688125,153
$0.714-0.017-2.4%$0.715$0.746$0.713149,318
$0.732-0.007-0.9%$0.73$0.738$0.713115,991
$0.738-0.029-3.8%$0.745$0.775$0.73205,291
$0.768+0.008+1.0%$0.77$0.799$0.755138,924
$0.76+0.008+1.1%$0.74$0.771$0.733255,714
$0.752-0.029-3.7%$0.773$0.792$0.741284,516
$0.781+0.033+4.4%$0.737$0.84$0.731,287,800
$0.749-0.041-5.2%$0.81$0.835$0.749320,051
$0.790.000.0%$0.789$0.81$0.77190,986
$0.79-0.112-12.4%$0.86$0.86$0.78374,771
$0.902+0.165+22.4%$0.74$0.928$0.742,259,615
$0.737+0.066+9.9%$0.67$0.76$0.664943,166
$0.671+0.03+4.7%$0.62$0.71$0.62443,311
$0.641-0.005-0.7%$0.66$0.673$0.619189,308
$0.645-0.02-3.0%$0.665$0.665$0.63181,871
$0.665-0.031-4.4%$0.676$0.69$0.665158,017
$0.696+0.001+0.2%$0.681$0.70$0.671154,486
$0.694+0.003+0.5%$0.696$0.706$0.675181,562
$0.691-0.001-0.1%$0.69$0.71$0.68192,179
$0.691+0.011+1.7%$0.68$0.706$0.68147,172
$0.68-0.007-1.1%$0.68$0.72$0.68177,131
$0.688-0.022-3.2%$0.68$0.70$0.68178,874
$0.71-0.012-1.7%$0.721$0.724$0.695260,534
$0.722-0.003-0.4%$0.721$0.74$0.72283,836
$0.725-0.014-1.9%$0.735$0.739$0.721165,527
$0.739+0.001+0.1%$0.716$0.744$0.716273,533
$0.738-0.007-1.0%$0.739$0.745$0.692345,654
$0.745-0.008-1.1%$0.747$0.755$0.73534,457
$0.754-0.011-1.4%$0.761$0.765$0.72431,954
$0.764+0.002+0.3%$0.74$0.78$0.74353,029
Ticker
NASDAQ:HOTH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Hoth Therapeutics, Inc. news

Hoth Therapeutics, Inc. on 6ix

News releases
22 in the last 12 months · 203 in all · newest Jun 15, 2026 · oldest 2019
Decks
7 decks · latest October 2025

Where Hoth Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HOTH · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HOTHBOATSUnited StatesUSD

Valuation

price Nov 19, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
1.73

Team and board

OfficerRole
Robb KnieFounder, President, and Chief Executive Officer
David BrionesChief Financial Officer
Hayley SpringerExecutive Vice President Operations

Decks

DeckKindSlidesDate
Investor Presentation (October 2025)Investor deck24 slidesOctober 2025
Investor Presentation (June 2025)Investor deck28 slidesJune 2025
Investor Presentation (December 2024)Investor deck33 slidesDecember 2024
Investor Presentation (August 2023)Investor deck33 slidesAugust 2023
Investor Presentation (September 2022)Investor deck39 slidesSeptember 2022
Investor Presentation (April 2022)Investor deck46 slidesApril 2022
Investor Presentation (October 2019)Investor deck33 slidesOctober 2019

Open Decks

Cap table

Built by 6ix from Hoth Therapeutics, Inc.’s releases

Common shares
16,270,499
Fully diluted
16,270,499

Fully diluted

LineShares
Common shares16,270,499

Share count over time

CountShares
Nov 22, 202616,270,499

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard768K4.7%US$548KSep 30, 2026
Geode Capital274K1.7%US$196KSep 30, 2026
Jane Street95,5180.59%US$68,219Sep 30, 2026
State Street63,9390.39%US$45,665Sep 30, 2026
UBS57,8430.36%US$41,300Sep 30, 2026
LPL Financial LLC41,0290.25%US$29,303Sep 30, 2026
Lido Advisors, LLC39,0000.24%US$27,854Sep 30, 2026
Northern Trust38,7240.24%US$27,657Sep 30, 2026
Virtu Financial LLC37,4420.23%US$27,000Sep 30, 2026
Susquehanna28,4360.17%US$20,309Sep 30, 2026
All 23 holders
HolderSharesOf the companyValueAs of
Raymond James Financial Inc14,6300.09%US$10,449Sep 30, 2026
StoneX Group Inc.12,1450.07%US$9,725Sep 30, 2026
Morgan Stanley12,0060.07%US$8,575Sep 30, 2026
Schwab10,0000.06%US$7,142Sep 30, 2026
Tower Research Capital LLC (TRC)8,3550.05%US$5,967Sep 30, 2026
SBI Securities Co., Ltd.4,5740.03%US$3,267Sep 30, 2026
MassMutual Private Wealth & Trust, FSB4,4000.03%US$3,142Sep 30, 2026
Farther Finance Advisors, LLC4,2370.03%US$3,026Sep 30, 2026
Osaic Holdings, Inc.2,7010.02%US$1,917Sep 30, 2026
Nuveen1,8960.01%US$1,387Sep 30, 2026
Federation des caisses Desjardins du Quebec350<0.01%US$250Sep 30, 2026
McGuire Capital Advisors Inc50<0.01%US$36Sep 30, 2026
IFP Advisors, Inc45<0.01%US$32Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund505K3.1%US$505KJun 30, 2026
Vanguard Extended Market Index Fund130K0.80%US$130KJun 30, 2026
Fidelity Extended Market Index Fund119K0.73%US$174KMay 31, 2026
Fidelity Nasdaq Composite Index Fund31,7110.19%US$46,298May 31, 2026
Fidelity Series Total Market Index Fund16,9790.10%US$24,789May 31, 2026
Fidelity Total Market Index Fund16,0760.10%US$23,471May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anthony C. Hayes
Other companies: SIM Acquisition Corp. I (Director · Since at least Mar 7, 2026); Dominari Holdings Inc. (CEO & Chairman of the Board · Since at least Sep 10, 2013); Revelation Biosciences, Inc. (Director · Oct 7, 2020 – Oct 7, 2020 · Past)
Director · Feb 14, 2019 – Dec 31, 2019 · Past
David Briones
Other companies: Unique Logistics International Inc (Director · Sep 6, 2022 – May 14, 2025 · Past); ZyVersa Therapeutics, Inc. (Chief Financial Officer, Director · Dec 20, 2021 – Jan 6, 2022 · Past)
Chief Financial Officer · Since at least Mar 5, 2019
Wayne D. Linsley
Other companies: Silo Pharma, Inc. (Board Member · Since at least May 23, 2025); Myseum.AI, Inc. (Director · Since at least Jan 14, 2025)
Director · Jul 17, 2023 – Aug 19, 2024 · Past
Christopher Michael CamarraDirector · May 8, 2025 – May 8, 2025 · Past
Hayley SpringerExecutive Vice President Operations · Since at least Nov 5, 2026
Robb KnieFounder, President, and Chief Executive Officer · Since at least May 26, 2026

Open People

Log in to ask 6ix AI your own questions about Hoth Therapeutics, Inc.